European Journal of Pediatrics

, Volume 129, Issue 4, pp 239–257 | Cite as

Lymph node plasmacytoma in a child: Clinical and immunological findings with special reference to S-Ig and complement receptor subtypes

  • K. Kruse
  • H. Stein
  • W. H. Hitzig
  • P. Joller
  • U. Lasson
Article
Received:

Abstract

A ten year-old girl presented with increased susceptibility to infection, massive enlargement of the cervical lymph nodes, a high erythrocyte sedimentation rate and an extremely high serum IgA (peak level 66 g/l). The diagnosis of plasmacytoma was confirmed by the identification of a monoclonal immunoglobulin (IgAk) in the serum and in the plasma cells present in a cervical lymph node biopsy. Her disturbed blood coagulation and thrombelastogram, serum hyperviscosity, cryoglobulinemia, hyponatremia and constantly positive test for rheumatoid factor without evidence of rheumatic disease were attributed to the effects of the myeloma proteins. Other signs often associated with plasmacytoma (bone pain, osteolytic lesions, anemia, bone marrow failure or infiltration) were absent indicating that the plasmacytoma originated in a lymph node, which is unusual. This case is the second well-documented childhood plasmacytoma to be reported. With combined melphalan and prednisone therapy, the greatly enlarged lymph nodes regressed in size and the plasma IgA concentration fell to normal.

Immunological investigations revealed a considerable reduction of blood T cells, and abnormal skin tests at the time of diagnosis indicated a disturbance of cellular immunity. There were also abnormalities in the B-cell system. The blood B lymphocytes were found to carry only complement receptors for C3b and mainly for IgA, whereas in normal individuals blood B cells bear complement receptors for both C3b and C3d and mainly surface Ig of the IgM class. In the lymph node biopsy, there were many primary follicles expressing complement receptors for both C3b and C3d among the dense plasma cell infiltrates, but germinal centers, which mainly serve to renew B cells, were completely absent.

In conjunction with data from the literature, we concluded 1) that the production of normal B lymphocytes is blocked, probably due to a secondary T cell deficiency, and 2) that the majority of the residual blood and bone marrow B cells and the plasmacytoma cells are parts of the same neoplastic cell clone.

Key words

Plasmacytoma Monoclonal gammopathy Lymph node plasmacytoma Surface markers Complement receptor subtypes 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alexanian, R., Haut, A., Khun, A. U., Lane, M., McKelvey, E. M., Migliore, P. J., Stuckey, W. J. Jr., Wilson, H. E.: Treatment for multiple myeloma: Combination chemotherapy with different melphalan dose regimens. JAMA 208, 1680–1685 (1969)Google Scholar
  2. 2.
    Barandun, S., Carrel, S., Gerber, H., Morell, A., Riesen, W., Skvaril, F.: Eine neue Methode zur Erfassung und Typisierung monoklonaler Immunglobuline (Doppellinienmethode). Schweiz. med. Wschr. 101, 955–964 (1971)Google Scholar
  3. 3.
    Beraud, C.: Rare cranial tumors in children. J. Radiol. Electrol. Med. 35, 523–526 (1954)Google Scholar
  4. 4.
    Borsos, T., Rapp, H. J.: Immune hemolysis: A simple method for the preparation of EAC4 with guinea pig or human complement. J. Immunol. 99, 263–268 (1967)Google Scholar
  5. 5.
    Costa, G., Engle, R. L., Schilling, A., Carbone, P., Kochwa, S., Nachman, R., Glidewell, O.: Melphalan and prednisone: An effective combination for the treatment of multiple myeloma. Amer. J. Med. 54, 589–599 (1973)Google Scholar
  6. 6.
    Fateh-Moghadam, A.: Paraproteinämische Hämoblastosen. Handbuch der Inneren Medizin II/5 (ed. H. Schwiegk), pp. 245–452. Heidelberg: Springer 1974Google Scholar
  7. 7.
    Frick, P. G., Schmid, J. R., Kistler, H. J., Hitzig, W. H.: Hyponatremia associated with hyperproteinemia in multiple myeloma. Helv. Med. Acta 33, 317–329 (1966)Google Scholar
  8. 8.
    Gilmore, M. E.: Multiple myeloma syndrome in a child. Tex. State J. Med. 21, 358–362 (1925)Google Scholar
  9. 9.
    Gordon, H., Schneider, B.: Plasma cell myeloma in a child. Int. Clin. 4, 173 (1940)Google Scholar
  10. 10.
    Harris, J. E., Alexanian, R., Hersh, E., Migliore, P.: Immuno function in multiple myeloma. Impaired responsiveness to keyhole hemocyanin. Can. Med. Assoc. J. 104, 389–393 (1971)Google Scholar
  11. 11.
    Hewell, C. M., Alexanian, R.: Multiple myeloma in young persons. Ann. Intern. Med. 84, 441–443 (1976)Google Scholar
  12. 12.
    Jackson, H. Jr., Parker, F. Jr., Bethea, J. M.: Studies of diseases of lymphoid and myeloid tissues: II. Plasmatocytomata and their relation to multiple myeloma. Amer. J. Med. Sci. 181, 169–180 (1931)Google Scholar
  13. 13.
    Jacobson, E. B., Caporale, L. H., Thorbecke, G. J.: Effect of thymus cell injections on germinal center formation in lymphoid tissues of nude (thymusless) mice. Cell. Immunol. 13, 416–430 (1974)Google Scholar
  14. 14.
    Jacoby, P.: Myelomatosis in a child of 8 years. Acta Radiol. 11, 224–232 (1930)Google Scholar
  15. 15.
    Kaufman, J.: Isolated myeloma in a fourteen-year-old boy. Amer. J. Surg. 69, 129–132 (1945)Google Scholar
  16. 16.
    Laurell, C.-B.: Electroimmuno assay. Scand. J. clin. Lab. Invest. 29, Suppl. 124, 21–37 (1972)Google Scholar
  17. 17.
    Laurentius, P.: Multiples Myelom im Kindesalter. Mschr. Kinderheilk. 73, 519–552 (1938)Google Scholar
  18. 18.
    Maeda, K., Abesamis, C., Kuhn, L. M., Hyun, B. H.: Multiple myeloma in childhood: Report of a case with breast tumors as a presenting manifestation. Amer. J. Clin. Pathol. 60, 552–558 (1973)Google Scholar
  19. 19.
    Mellstedt, H., Hammarström, S., Hahn, G.: Monoclonal lymphocyte population in human plasma cell myeloma. Clin. Exp. Immunol. 17, 371 (1974)Google Scholar
  20. 20.
    Nelson, M. G., Lyons, A. R.: Plasmacytoma of lymph glands. Cancer 10, 1275–1280 (1957)Google Scholar
  21. 21.
    Nieuwenhuis, P., van Nonhuijs, C. E., Eggers, J. H., Keuning, F. J.: Germinal centres and the origin of the B-cell system. I. Germinal centres in the rabbit appendix. Immunology 26, 497–567 (1974)Google Scholar
  22. 22.
    Poole, A., Marchetta, F. C.: Extramedullary plasmacytoma of the head and neck. Cancer 22, 14–21 (1968)Google Scholar
  23. 23.
    Porush, J. G., Grishman, E., Alter, A. A., Mandelbaum, H., Churg, J.: Paraproteinemia and cryoglobulinemia associated with atypical glomerulonephritis and the nephrotic syndrome. Amer. J. Med. 47, 957–964 (1969)Google Scholar
  24. 24.
    Porter, F.: Multiple myeloma in a child. J. Pediatr. 62, 602–604 (1963)Google Scholar
  25. 25.
    Rubinstein, M. A.: Multiple myeloma as a form of leukemia. Blood 4, 1049–1067 (1949)Google Scholar
  26. 26.
    Ross, G. D., Polley, M. J.: Specificity of human lymphocyte complement receptors. J. exp. Med. 141, 1163–1180 (1975)Google Scholar
  27. 27.
    Salmon, S. E., Fudenberg, H. H.: Abnormal nucleic acid metabolism of lymphocytes in plasma cell myeloma and macroglobulinemia. Blood 30, 300–312 (1969)Google Scholar
  28. 28.
    Schedel, I., Schöner, W., Ziegler, R., Kalden, J. R., Deicher, H.: Idiotypic determinants and antiglobulins in multiple myeloma. Haematology and Blood Transfusion, Vol. 20 (eds. Thierfelder, S., Rodt, H., Thiel, E.), pp. 329–332. Berlin-Heidelberg-New York: Springer 1977Google Scholar
  29. 29.
    Scheidegger, J. J.: Une micromethode d'immunoelectrophorese. Int. Arch. Allergy and App. Immun. 7, 103–106 (1955)Google Scholar
  30. 30.
    Seligmann, M., Preud'homme, J.-L., Bronet, J.-C.: B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins. Transplant. Rev. 16, 85–113 (1973)Google Scholar
  31. 31.
    Simon, M. A., Eidlow, S.: Plasmacytoma of lymph node. Report of a case with multiple myeloma. New Engl. J. Med. 243, 335–338 (1950)Google Scholar
  32. 32.
    Slavens, J.: Multiple myeloma in a child. Amer. J. Dis. Child. 47, 821–835 (1934)Google Scholar
  33. 33.
    Stein, H., Parwaresch, M. R.: Lokalisation der IgM-Fraktion in diskontinuierlichen Polyacrylamid-Elektrophorese-Säulen. Blut 23, 104–112 (1971)Google Scholar
  34. 34.
    Stein, H., Parwaresch, M. R., Koper, G., Mäder, Ch.: Elektrophoretische Darstellung von 19S IgM in diskontinuierlichen Polyacrylamid-Säulen. Klin. Wschr. 51, 1050–1058 (1973)Google Scholar
  35. 35.
    Suissa, L., LaRosa, J., Linn, B.: Plasmacytoma of lymph nodes. JAMA 197, 136–138 (1966)Google Scholar
  36. 36.
    Vossen, J.: The development of the B immune system in man. Proefschrift, Rotterdam (1975)Google Scholar
  37. 37.
    Weksler, M. E., Hutteroth, T. H.: Impaired lymphocyte function in aged humans. J. Clin. Invest. 53, 99–104 (1974)Google Scholar
  38. 38.
    Whitsed, H. M., Penny, R.: IgA/IgG cryoglobulinaemia with vasculitis. Clin. exp. Immunol. 9, 183–191 (1971)Google Scholar
  39. 39.
    Whittaker, J. A., Tuddenham, E. G. D., Bradley, J.: Hyperviscosity syndrome in IgA multiple myeloma. Lancet 1973 II, 572Google Scholar
  40. 40.
    Zäh, K.: Über Myelom im kindlichen Alter. Virchows Arch. f. path. Anat. 283, 310–320 (1932)Google Scholar

Copyright information

© Springer-Verlag 1978

Authors and Affiliations

  • K. Kruse
    • 1
  • H. Stein
    • 2
  • W. H. Hitzig
    • 3
  • P. Joller
    • 3
  • U. Lasson
    • 1
  1. 1.Department of PediatricsUniversity of KielKielGermany
  2. 2.Department of PathologyUniversity of KielKielGermany
  3. 3.Department of PediatricsUniversity of ZürichZürichSwitzerland

Personalised recommendations